Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study

1. Joura, E.A.
2. Ulied, A.
3. Vandermeulen, C.
4. Rua Figueroa, M.
5. Seppä, I.
6. Hernandez Aguado, J.J.
7. Ahonen, A.
8. Reich, O.
9. Virta, M.
10. Perino, A.
11. Peris Tuser, M.
12. Peters, K.
13. Origoni, M.
14. Raspagliesi, F.
15. Tjalma, W.A.A.
16. Tummers, P.
17. Woelber, L.
18. Nieminen, P.
19. van Damme, P.
20. Sehouli, J.
21. Fiol Ruiz, G.
22. Brucker, S.
23. Fehm, T.
24. Cheon, K.
25. Rawat, S.
26. Luxembourg, A.
27. Wittke, F.
28. Mostrar todos los/as autores/as +